FDA Issues Warning to Drugmaker for Misleading Email Promotion
05 Jun 2026 //
RAPS
FDA Issues Untitled Letter Over `Eye-Catching` Promo Graphics
03 Jun 2026 //
FIERCE PHARMA
Evoke Pharma And QOL Medical Announce Expiration Of Tender Offer
17 Dec 2025 //
PR NEWSWIRE
QOL Medical CEO Increases Faith-Based Donations
31 Mar 2025 //
PR NEWSWIRE
QOL Medical CEO Donates $75,000 to Beacon Rescue and Relief
21 Mar 2025 //
PR NEWSWIRE
FDA-Approved Sucraid Offers Free 4-Day Trial for CSID Treatment
01 Mar 2025 //
PR NEWSWIRE
QOL MEDCL`s Biologic Sucraud (Sacrosidase) Receives Suppl Approvals in US
02 Aug 2024 //
FDA
QOL Medical, LLC receives FDA approval of Sucraid
06 Sep 2022 //
PRNEWSWIRE

Market Place
Sourcing Support